Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors

BACKGROUND: Targeted therapy has been established as the standard-of-care for patients with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations. Among patients with advanced lung cancer, 30–40% have bone metastases (BoM) at first diagnosis. However, lit...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Bone Oncol
Päätekijät: Chen, Yue-Yun, Wang, Pei-Pei, Fu, Yang-, Li, Qing-, Tian, Jiang-Fang, Liu, Ting-, Lin, Zhen, Ding, Zhen-Yu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2021
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8138759/
https://ncbi.nlm.nih.gov/pubmed/34036039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2021.100369
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia